Sign Out
Betnovate-N Cream is especially appropriate for moist or weeping surfaces. In adults, in the more resistant lesions, such as the thickened plaques of psoriasis on elbows and knees, the effect of Betnovate-N can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response in such cases, thereafter improvement can usually be maintained by regular application without occlusion.
Treatment should not be continued for more than 7 days without medical supervision. When the product is used on the face, the treatment should not be longer than 5 days and occlusive dressing should not be applied.
Adults and children aged 2 years and over: A small quantity should be applied to the affected area two or three times daily until improvement occurs. It may then be possible to maintain improvement by applying once a day or even less often.
Betnovate-N is suitable for use in children (2 years and over) at the same dose as adults. When used in children, courses should be limited to 5 days, if possible.
A possibility of increased absorption exists in very young children, thus Betnovate-N is not recommended for use in neonates and infants younger than 2 years of age (see Contraindications).
Dosage in renal/hepatic impairment: In case of systemic absorption and the development of systemic reactions (when the product is applied over a large surface area for a prolonged period), the metabolism and elimination may be delayed, thus increasing the risk of systemic toxicity. Consequently, the minimum recommended dose should be used for the shortest duration necessary to treat the disease. (See Precautions.)
Elderly: Betnovate-N is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur (see Precautions).
For topical administration.
